Blog

Clinical Trial’s Most Valuable Asset

June 28, 2019

Do you know what the most valuable asset from your clinical trial is? On June 12, 2019, the Duke Margolis...

Blog

60-Day Review for Clinical Trials Works in China

May 23, 2019

The days appear to be over when obtaining regulatory approval for clinical trials in China generally took a year and...

Blog

Brexit Blog Series: The Fog Remains

March 25, 2019

Recently, the British Parliament voted three times on Brexit. Based on the outcomes, the most likely scenario will be a...

Blog

Recent Biotech IPO Analysis

March 25, 2019

Investor interest in biotechnology companies has been extremely high over the past several years. Previous articles have discussed the increase in biotech FDA...

Blog

Biotech FDA Approvals Peak

February 21, 2019

Last September, I discussed how increased biotech funding is having a material effect on overall pharmaceutical research and development spend. The output of...

Blog

Biotech’s Impact on Drug Development

September 5, 2018

Private and public funding for biotechnology investments have occurred at a record breaking pace over the past twelve months. Incredibly, according to...

Blog

EMA Issues Guideline on GMP for Advanced Therapy Medicinal Products

January 2, 2018

  On November 22, 2017 the European Commission published the first guideline for GMP for Advanced Therapy Medicinal Products which...

Blog

Schedule Crashers

November 28, 2017

How to identify and mitigate risks to keep your timeline on track. Biopharma companies can be an optimistic bunch –...

Blog

Sound Clinical Strategies: 9 key questions every biopharma team should ask themselves

November 4, 2017

How asking the right questions during clinical development planning can prevent costly mistakes down the line. When a biopharma company,...

Blog

Kidney Week 2017 Examines the Future of Personalized Nephrology

October 19, 2017

Next week, I’ll be heading to New Orleans to join 13,000 other kidney professionals at the American Society of Nephrology’s...

When you have clinical research and development questions, the answer is Clearly Clinipace.

Get in Touch